View More Recent Stories

Sep 18, 2019 01:00PM Divide & Conquer, Developing New Class of Cancer Therapeutics to Disrupt Cell-to-Cell Communication, Emerges from Stealth as New Paper by Co-Founder is Published in Nature
Oct 8, 2018 06:50PM Genmab and Seattle Genetics Announce Tisotumab Vedotin Data to Be Presented at ESMO 2018 Congress
Oct 10, 2017 06:44AM Genmab and Seattle Genetics to Initiate New Study of Novel Antibody-Drug Conjugate Tisotumab Vedotin in Cervical Cancer
Oct 10, 2017 06:19AM Genmab and Seattle Genetics to Initiate New Study of Novel Antibody-Drug Conjugate Tisotumab Vedotin in Cervical Cancer
May 2, 2017 05:05PM Kindred Issues 2017 Quality, Innovation and Social Responsibility Report
Feb 27, 2017 04:30PM Kindred Healthcare Reports Fourth Quarter 2016 Results
Jan 31, 2017 04:30PM Genesis HealthCare and Kindred Form Strategic Clinical Collaboration to Improve Quality, Outcomes and Care Transitions across the Post-Acute Continuum
View More Recent Stories